Trexquant Investment’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,296
Closed -$227K 1624
2021
Q2
$227K Buy
+13,296
New +$249K 0.02% 850
2021
Q1
Sell
-10,954
Closed -$251K 1604
2020
Q4
$251K Buy
+10,954
New +$209K 0.03% 791
2019
Q1
Sell
-18,850
Closed -$531K 1415
2018
Q4
$531K Buy
+18,850
New +$552K 0.03% 596
2015
Q3
Sell
-24,300
Closed -$695K 1338
2015
Q2
$695K Buy
24,300
+13,610
+127% +$357K 0.08% 484
2015
Q1
$276K Buy
+10,690
New +$244K 0.03% 856

Other funds holding XENT

Trexquant Investment's XENT Position: Q3 2021 in Review

Trexquant Investment sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 13,296 shares — an estimated $227K sold.

Trexquant Investment first reported a position in XENT in Q1 2015 and held it in 5 quarters. The position peaked at $695K in Q2 2015. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Trexquant Investment reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Trexquant Investment sold 13,296 Intersect ENT, Inc shares in Q3 2021, an estimated $227K.
  • Trexquant Investment first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 5 quarters.
  • Trexquant Investment's Intersect ENT, Inc position peaked at $695K in Q2 2015.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.